You just read:

American Diversified Holdings Corporation Completes Cost Projection "USE OF FUNDS" to Develop the Brazos Biomedical Non-Opioid AURACISTM "Tens" Migraine Management System

News provided by

American Diversified Holdings Corporation

Aug 01, 2018, 06:00 ET